SequelSEC

Core Laboratories Inc. /DE/ CLB

Oil & Gas Field Services, NEC · CIK 0001958086 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$132.08M
Fiscal year ended 2026-09-30
Operating income
$12.06M
Fiscal year ended 2026-09-30
Free cash flow
$1.72M
Fiscal year ended 2026-09-30

Valuation, from the filing

Public float$498.91MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$10.83Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income16.8×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue0.9×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.8×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

Valuation over time

16.8× earnings today, against a median of 29.2× across 3 years on record. Below its own history.

Float measuredPublic floatFloat / net income
2025-06-30$498.91M16.8×
2024-06-30$938.38M29.9×
2023-06-30$1.07B29.2×

Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.

How this compares in its industry

Percentile among the Oil & Gas Field Services, NEC filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
CapEx / revenue2.1%8th
SBC / revenue1.4%88th
Effective tax rate33.8%82th
Operating margin10.7%81th
FCF margin4.9%67th
Net margin5.6%67th
Current ratio2.02x65th
Long-term debt / equity0.41x64th
Revenue YoY growth0.5%59th
Gross margin20.7%50th

Core Laboratories Inc. /DE/ (CLB) reported revenue of $132.08M and net income of $5.44M for the fiscal year ended 2026-09-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Core Laboratories Inc. /DE/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Oil & Gas Field Services, NEC.

Income

Core Laboratories Inc. /DE/ income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Revenue$132.08M$124.61M$121.80M$138.26M$134.52M$130.16M$123.58M$129.24M$134.40M$130.58M
Cost of revenue$105.09M$101.37M$102.07M$109.52M$104.90M$103.70M$99.47M$106.20M$106.80M$102.93M
Gross profit$26.98M$23.24M$19.72M$28.74M$29.62M$26.46M$24.12M$23.04M$27.59M$27.65M
Operating income$12.06M$9.15M$1.89M$15.83M$20.93M$15.29M$4.42M$14.17M$19.80M$16.01M
Net income$5.44M$5.96M-$789.00K$4.95M$14.24M$10.64M-$154.00K$7.40M$11.74M$9.03M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 46.71Mshares 46.88Mshares 46.07MUnavailableshares 47.08Mshares 47.36Mshares 46.77MUnavailableshares 47.82Mshares 47.74M
Pretax income$9.28M$6.30M-$1.00M$13.22M$18.28M$12.58M$1.82M$11.54M$16.70M$12.80M
Income tax expense$3.82M$507.00K-$251.00K$8.09M$3.75M$1.91M$1.75M$4.08M$4.69M$3.61M
Diluted EPS$0.12$0.13$-0.02Unavailable$0.30$0.22$0.00Unavailable$0.25$0.19
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$11.27M$10.95M$14.72M$10.63M$10.69M$10.46M$13.65M$9.08M$8.64M$10.26M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Core Laboratories Inc. /DE/ balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash & equivalents$21.38M$22.74M$22.82M$22.70M$25.63M$31.19M$22.11M$19.16M$21.47M$17.70M
Total assets$593.52M$586.78M$587.73M$584.01M$586.08M$596.84M$586.24M$585.13M$600.47M$597.80M
Current assets$225.06M$214.36M$214.37M$214.66M$226.91M$237.68M$228.77M$221.33M$235.23M$233.53M
Total liabilitiesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current liabilities$102.73M$101.05M$104.73M$106.02M$95.74M$104.77M$103.73M$102.44M$94.94M$97.60M
Total equity incl. NCI$284.09M$278.77M$275.14M$272.21M$271.97M$261.88M$253.94M$252.32M$256.42M$245.69M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$60.70M$57.96M$57.78M$54.50M$58.24M$59.77M$59.03M$59.40M$65.49M$69.90M
Accounts receivable$115.57M$108.82M$108.28M$113.53M$110.26M$113.91M$117.03M$111.76M$117.59M$115.64M
Goodwill$105.92M$105.80M$105.80M$105.79M$100.01M$100.00M$99.44M$99.44M$99.44M$99.44M
Long-term debt$112.45M$113.86M$114.46M$110.26M$114.10M$124.61M$124.37M$126.11M$139.87M$147.62M
Accounts payable$40.01M$40.16M$39.98M$37.28M$36.94M$41.70M$38.50M$34.55M$33.63M$36.86M

Cash flow

Core Laboratories Inc. /DE/ cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Operating cash flow$4.97M$7.81M$3.96M$7.95M$8.50M$13.92M$6.66M$20.62M$13.10M$17.15M
Capital expenditures$3.25M$4.69M$3.45M$2.94M$2.01M$3.47M$2.78M$3.24M$2.73M$2.87M
Investing cash flow-$3.19M-$3.93M-$3.39M-$3.75M$2.39M-$1.64M$772.00K-$3.56M-$491.00K-$687.00K
Financing cash flow-$3.14M-$3.96M-$457.00K-$7.12M-$16.45M-$3.20M-$4.48M-$19.37M-$8.83M-$13.68M
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensation$1.28M$902.00K$5.03M$1.11M$1.33M$538.00K$4.16M-$458.00K-$475.00K-$132.00K
Common dividends paid$459.00K$460.00K$460.00K$466.00K$465.00K$469.00K$469.00K$469.00K$469.00K$470.00K
Common share repurchases$1.05M$2.69M$4.00M$2.66M$5.01M$2.74M$2.02M$4.90M$196.00K$162.00K
Depreciation & amortization$3.72M$3.82M$3.76M$3.67M$3.59M$3.67M$3.72M$3.66M$3.68M$3.77M

Derived

Core Laboratories Inc. /DE/ derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Free cash flow$1.72M$3.12M$517.00K$5.00M$6.50M$10.45M$3.88M$17.37M$10.37M$14.28M
Gross margin20.4%18.6%16.2%20.8%22.0%20.3%19.5%17.8%20.5%21.2%
Operating margin9.1%7.3%1.5%11.5%15.6%11.7%3.6%11.0%14.7%12.3%
FCF margin1.3%2.5%0.4%3.6%4.8%8.0%3.1%13.4%7.7%10.9%
SBC / revenue1.0%0.7%4.1%0.8%1.0%0.4%3.4%-0.4%-0.4%-0.1%
Current ratio2.19x2.12x2.05x2.02x2.37x2.27x2.21x2.16x2.48x2.39x
Revenue YoY growth-1.8%-4.3%-1.4%7.0%0.1%-0.3%-4.7%0.8%7.2%2.1%
Net margin4.1%4.8%-0.6%3.6%10.6%8.2%-0.1%5.7%8.7%6.9%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue2.5%3.8%2.8%2.1%1.5%2.7%2.3%2.5%2.0%2.2%
Long-term debt / equity0.40xUnavailableUnavailable0.41xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate41.1%8.0%Unavailable61.2%20.5%15.2%96.2%35.3%28.1%28.2%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CLB in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-10-30View SEC filing
10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-05-01View SEC filing
10-K · Filed 2026-03-23View SEC filing
10-Q · Filed 2025-10-23View SEC filing
10-Q · Filed 2025-07-25View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.